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Objective: Conventional methods such as duplex ultrasound scanning do not provide accurate information about proximal
extension of pelvic vein thrombosis. We evaluated proximal extent of thrombus toward pelvic veins with magnetic
resonance imaging in patients with suspected deep vein thrombosis (DVT) proximal to the inguinal ligament on the basis
of duplex ultrasound scans. In addition, frequency of pulmonary embolism (PE) and early (4 weeks) clinical outcome
were evaluated.
Methods: Two hundred twelve patients with acute symptomatic DVT proximal to the inguinal ligament, diagnosed at
duplex ultrasound scanning, were enrolled in this prospective study. All patients underwent magnetic resonance imaging
of the abdominal and pelvic veins, as well as lung scintigraphy to detect the presence of pumonary embolism.
Results: In 24 of 212 patients (11%), thrombus was restricted to the femoral vein. The thrombus extended into iliac veins
in 142 patients (67%) and into the inferior vena cava in 46 patients (22%). The frequency of PE was not associated with
the most proximal extension of thrombus (P  .61). No patients died as a consequence of thromboembolic events.
Conclusions: Extension of DVT into the inferior vena cava occurs relatively frequently. In our patients this finding was not
associated with higher risk for PE compared with DVT of the femoral or iliac veins. (J Vasc Surg 2003;37:518-22.)
Deep vein thrombosis (DVT) of the leg is a relevant
social and health care problem in which pulmonary embo-
lism (PE) is a common and sometimes fatal complica-
tion.1,2 Early diagnosis and treatment of DVT are essential
to minimize morbidity and mortality.
PE has been reported in 50% to 80% of patients with
DVT of the lower extremity.3-7 It is commonly believed
that risk for PE is significantly higher when DVT involves
proximal veins of the leg compared with distal veins of the
leg.8-13 Although proximal extent of DVT is important
with respect to risk for PE, few studies have examined the
frequency of extent of proximal DVT into the inferior vena
cava (IVC).
Conventional methods such as duplex ultrasound scan-
ning and contrast material-enhanced venography do not
provide accurate information concerning the most proxi-
mal extent of thrombi into the pelvic and abdominal veins
in patients with pelvic vein thrombosis.14-16 Technical ad-
vances have improved the accuracy of diagnostic studies in
patients with DVT, and magnetic resonance imaging
(MRI), in particular, has been successfully used to diagnose
proximal DVT.17-26
In the present study, MRI of the pelvic and abdominal
veins was used to determine the exact extent of thrombus in
patients thought to have DVT proximal to the inguinal
ligament on the basis of duplex sonographic scans. In
addition, lung scintigrams were obtained to determine the
frequency of PE in relation to proximal extent of DVT in
the leg. Finally, clinical outcome was evaluated after 4
weeks.
METHODS
Study design. This prospective study was performed
to evaluate the most proximal extent of thrombus with
MRI in patients with DVT proximal to the inguinal liga-
ment at duplex ultrasound scanning. The second aim of the
study was to evaluate the association between proximal
extent of thrombus and frequency of PE. In addition,
clinical outcome was evaluated. The criterion for inclusion
was DVT proximal to the inguinal ligament seen on a
duplex scan independent of the presence or absence of PE.
Patients with duplex scans that demonstrated DVT limited
to the femoral, popliteal, or calf veins were excluded.
Patient sample. Between 1992 and 2000, 1246 con-
secutive patients with symptomatic DVT of the leg, diag-
nosed with duplex ultrasound scanning, received treatment
in our department. In 1006 patients, the thrombus was
located distal to the inguinal ligament (femoral vein throm-
bosis, popliteal vein thrombosis, or calf vein thrombosis).
In a subsequent series of 240 patients, DVT proximal to the
inguinal ligament was diagnosed with duplex ultrasound
scanning; these patients were eligible for the study. In all of
them, thrombosis was considered to be in a suprainguinal
location after the initial duplex scanning examination. All
patients had characteristic clinical signs of DVT, ie, swell-
ing, pain, and hyperthermia. The referral time between
onset of symptoms, diagnosis, and treatment ranged from a
few hours to a few days. Two patients (0.9%) had phlegma-
sia cerulea dolens.
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Eligible patients were identified by the study coordina-
tor and invited to undergo MRI. Of 240 patients, 28 were
excluded from the study because they declined the diagnos-
tic procedure or had exclusion criteria such as claustropho-
bia, metal implants, or a pacemaker; the remaining 212
patients were included in the study. Written informed
consent was obtained from all patients.
The study was conducted by the Department of Der-
matology, Wilhelminenspital, Vienna, Austria, where one
area of interest is thromboembolic disease. Nearly all pa-
tients who are referred to our hospital with suspected DVT
of the leg are first examined in our department. Patients
with massive PE (degree 4) are primarily transferred to the
intensive care unit and therefore were not eligible for our
study. Thus our study results can be considered applicable
to all patients who are not primarily referred to the intensive
care unit.
Diagnostic procedure for DVT. All ultrasound ex-
aminations were performed with a duplex scanner (Diason-
ics Ultrasound, General Electric Ultrasound Europe, Solin-
gen, Germany). A 3 or 5 MHz probe was used for the
examination, depending on patient anatomy and necessary
depth of penetration for optimal imaging of the deep veins.
Duplex scanning criteria for venous thrombosis included
visualization of the thrombus in the B-mode, lack of venous
compressibility, and characteristic changes in Doppler flow
signal (eg, lack of phasic flow with respiration, absence of
augmentation with compression of muscle, cessation of
flow with Valsalva maneuver) distal to the suspected site of
thrombosis.
The proximal extent of the thrombus was evaluated
(infrainguinal or suprainguinal extension). The results of
duplex scanning were printed for documentation. The pop-
liteal segment and distal venous segment, including the
posterior tibial, peroneal, gastrocnemic, and soleal veins,
also were scanned routinely, as well as the asymptomatic
contralateral lower extremity.
MRI. To determine the exact proximal extent of
thrombus, MRI of the pelvic and abdominal veins was
performed in 212 patients within 48 hours after duplex
ultrasound scanning. Based on the most proximal extent of
the thrombus, patients with pelvic vein thrombosis were
divided into three groups: DVT restricted to the femoral
veins (n 24), DVT that extended into the iliac veins (n
142), and DVT that extended into the IVC (n 46). MRI
was performed with a commercial imaging system operat-
ing at 1.0 T (Magnetom; Siemens Medical System, Erlan-
gen, Germany) with time- of-flight fast low-angle shot
two-dimensional sequencing and maximum intensity pro-
jection reconstruction. Sequence parameters were 31 msec;
echo time, 10 msec; flip angle, 40 degrees. Projection
magnetic resonance venography (MRV) was performed
with maximum intensity pixel reconstruction. No contrast
medium was used for MRV. A complete examination re-
quired on average 50 minutes. An MRV image result was
considered positive for DVT with the following criteria:
presence of a central signal void, with surrounding hyper-
intense signal on the MRV image caused by an intraluminal
filling defect with a central or lateral signal in relation to a
particular clot or clot repermeabilization; or absence of
venous flow on MRV with or without collateral vessels. At
the end of each MR examination, images were interpreted
by an independent radiologist blinded to clinical and diag-
nostic findings.
Ventilation and perfusion lung scanning. To detect
PE, perfusion lung scanning, and in doubtful cases ventila-
tion lung scanning, was performed in 207 patients within
48 hours after admission. In 5 patients, ventilation and
perfusion (V-P) lung scanning was not possible because of
technical problems. V-P lung scanning was performed after
intravenous injection of technetium 99m-labeled micro-
spheres. The microspheres were trapped in terminal pulmo-
nary arterioles, depending on regional blood flow. Images
in four views (anterior, posterior, right posterior oblique,
left posterior oblique) were obtained. When the perfusion
scan was normal, the investigation was terminated and no
additional ventilation studies were performed, because a
normal perfusion scan excluded PE with high certainty.27
When perfusion defects were seen on one or more views, an
additional inhalation scan with krypton 81 was obtained.
Each patient was examined in the upright position, and
after proper window setting, inhaled from the generator
system up to 300 K counts. Diagnosis of PE was set in
accord with the criteria of the PIOPED investigators.28
Supplementary examinations. All enrolled patients
were screened for malignancy with gynecologic and uro-
logic examinations, abdominal ultrasound scanning, search
for occult blood in stool, and enzyme tests. In addition,
complete blood and urine analysis, electrocardiography,
and chest radiography were performed in all patients. No
transoesophageal echocardiograms were obtained.
Treatment regimen. All patients received compres-
sion therapy and anticoagulation therapy. In addition, mo-
bile patients were kept mobile and were asked to walk.
Anticoagulation therapy. All patients were given low
molecular weight heparin (Fragmin; Pharmacia, Stock-
holm, Sweden) at a dose of 100 IU/kg body weight, twice
daily subcutaneously. The first dose was administered after
diagnosis of DVT with duplex scanning. After contraindi-
cations were excluded, oral anticoagulation treatment with
coumarin (Marcoumar; Roche, Basil, Switzerland) was
started. The coumarin dose was adjusted to achieve and
maintain an international normalized ratio (INR) of 2.0 to
3.0. Fragmin was applied in an overlapping fashion, in full
dose, until INR 2.0 to 3.0 was achieved. After 2 days of
INR 2.0 to 3.0, heparin was discontinued. Oral anticoag-
ulation therapy was administered independent of extent of
thrombus. Oral anticoagulation therapy was continued for
6 months in patients with a first thrombotic event and no
factors such as thrombophilia, and for at least 1 year in
patients with recurrent thrombosis.
Compression therapy. A firm compression bandage
(Unna boot) was applied to the affected leg from the foot
to the groin for at least 2 weeks or until swelling had
subsided. The compression bandage used on the lower leg
was nonelastic zinc plaster (Gelocast, Beiersdorf, Germany)
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overwrapped with short-stretch material (Comprilan,
Homburg, Germany). An adhesive bandage was applied on
the thigh, with considerable pressure over the knee up to
the groin. The bandages were changed every 3 days. After 2
weeks, class II compression stockings were used. No pa-
tient underwent surgery or thrombolysis, or received a
permanent or temporary caval filter.
Clinical outcome. All patients were followed up clin-
ically for 4 weeks. Thirty-one of 46 patients with IVC
thrombosis were followed up for 1 to 71⁄2 years (median,
221⁄2 months).
Statistical analysis. All data were computer tabulated
and analyzed. Data are presented as mean values (minimum
and maximal values) when appropriate. Differences be-
tween groups with respect to distribution of PE were tested
with a 2. P  .05 was considered statistically significant.
RESULTS
Patient characteristics. Two hundred twelve patients
with DVT proximal to the inguinal ligament, confirmed at
duplex sonography, were enrolled in the study. The series
included 101 men and 111 women, with a mean age of 68
years (range, 17-91 years). Only five patients (2.4%) had
bilateral DVT. All patients had characteristic clinical signs
of DVT, ie, swelling, pain, and hyperthermia, when they
were admitted to the hospital.
Proximal extent of thrombus. In all 212 patients,
MRI was performed to determine the exact proximal extent
of thrombus. In 188 of 212 patients (89%) MRI demon-
strated thrombus in the pelvic or abdominal veins. In 24
patients (11%) thrombus was restricted to the femoral vein.
In 142 of 188 patients (67%) with pelvic vein thrombosis,
thrombus extended into the iliac veins. In 46 patients
(22%) the most proximal portion of the thrombus extended
into the IVC (Table I).
In 142 patients with iliac vein thrombosis, thrombus
was confined to the left iliac veins in 92 (65%) and to the
right iliac veins in 45 (31%). Thus left iliac vein thrombosis
occurred twice as often as right iliac vein thrombosis. In 5
patients (4%) thrombus affected both iliac veins.
Pulmonary embolism. Two hundred seven patients
underwent perfusion scanning and, in addition, ventilation
lung scanning if the perfusion scan was abnormal. In five
patients V-P lung scanning was not possible because of
technical problems.
The extent of thrombus showed no correlation with
frequency of PE on admission to the hospital. Lung scans
demonstrated PE in 101 patients (49%). No significant
difference was noted in incidence of PE between patients
with femoral DVT (50%) and patients with pelvic vein
thrombosis (51%; P  .61) (Table I). Also, no significant
difference was found in frequency of PE in patients with
pelvic vein thrombosis with iliac vein thrombosis (51%) or
IVC thrombosis (42%; P  .05).
Furthermore, there was no statistical difference be-
tween patients with femoral DVT and those with pelvic
DVT (P  .05) with respect to incidence of clinically
symptomatic PE (degree 1-2). In patients with pelvic DVT,
there also was no significant difference in occurrence of
symptomatic PE (degree 1-2) between those with iliac vein
thrombosis and those with IVC thrombosis (P  .05). No
patient required mechanical ventilation or emergency sur-
gery. No new symptomatic PE developed in any patient
during hospitalization. Clinical progression of PE was not
observed in any instance. It should be emphasized that no
patient with asymptomatic PE developed pulmonary symp-
toms during follow-up.
Clinical outcome. All patients were followed up for 4
weeks. During this interval there were no deaths, major
bleeding, or recurrence of symptomatic thromboembolic
events.
Thirty-one of 46 patients with IVC thrombosis were
followed up for 1 to 71⁄2 years (median, 22.5 months) after
the first MRI; the other 15 patients were lost to follow-up.
Six patients with IVC thrombosis died during follow-up
(Table II), of malignant disease or myocardial infarction.
No patient died as a consequence of thromboembolic event
or major bleeding complication. Autopsies were performed
after all hospital deaths. Five patients were readmitted at
some point during long-term follow-up because of throm-
boembolic events: contralateral DVT in three and PE in
two patients. Four patients had a thromboembolic event
while receiving anticoagulation therapy. Twelve patients
with IVC thrombosis experienced chronic venous insuffi-
ciency, and a leg ulcer developed in one of these patients.
DISCUSSION
There are three principal findings of our study. First,
IVC involvement is a relatively frequent finding in patients
with proximal DVT. In 46 of 212 patients (22%) the most
proximal portion of the thrombus extended into the IVC.
It is worth noting that there were no differences in clinical
symptoms between patients with or without IVC involve-
ment.
Second, incidence of PE was equally distributed be-
tween patients with femoral DVT and patients with pelvic
vein thrombosis. Also, in patients with pelvic vein throm-
bosis there was no difference in incidence of PE between
patients with iliac or IVC thrombosis. Thus the risk for PE
did not correlate with extension of thrombus into the IVC.
Similar results were reported by Lusiani et al29 and Meigan
et al.30 They also found no relationship between risk for PE
and extension of thrombus in patients with DVT.
Table I. Proximal extent of thrombus diagnosed with









Pno % no % no %
Proximal extent of thrombus 24 11 142 67 46 22 .61Pulmonary embolism at
hospital admission
12 50 70 51 19 42
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Third, none of the patients in our study died as a
consequence of venous thromboembolism during fol-
low-up of at least 4 weeks. It should be emphasised that the
finding of clot in the IVC at MRI did not change our
treatment regimen with anticoagulation therapy, compres-
sion therapy, and walking. This is in accord with the out-
come of two randomized controlled trials comparing low
molecular weight heparin and bed rest36 with low molecu-
lar weight heparin, compression therapy, and walking.37
Neither study reported significant differences concerning
development of new PE diagnosed at repeat lung scanning.
Placement of an IVC filter is effective for prevention of
PE.32 However, because of complications in IVC place-
ment33-35 the routine use of filters remains controversial.
No filters were used in the present study, and it should be
noted that no patient died as a consequence of venous
thromboembolism.
MRI is an accurate method for evaluating proximal
DVT,17-26,38,39 with high sensitivity and specificity.19,20 In
contrast to duplex ultrasound scanning, MRI provides the
opportunity to study the IVC and the common and exter-
nal iliac veins.25,38,40 Pelvic vein thrombosis diagnosed
with duplex scanning could not be verified with MRI in 24
patients (11%). Published reports concerning the extension
of DVT of the lower extremity into the pelvic veins and IVC
are scarce3,40 and are mostly confined to small patient
samples.22 In the study of Evans et al,22 pelvic DVT was
diagnosed with MRI in only 1 of 75 patients with clinically
suspected DVT. However, the goal of that study was to
compare the accuracy of MRI and sonography, not to
evaluate the proximal extent of thrombus. Spritzer et al39
retrospectively investigated the relative frequency of DVT
confined to the pelvic veins with MRI and found isolated
pelvic vein thrombosis in 21.7% of patients. These authors
recommended MRI in patients with suspected pelvic DVT.
Previous trials have also investigated the frequency of
chronic venous insufficiency and recurrence rates after ve-
nous thromboembolism.41-48 In the present study, the
limited number of patients with IVC thrombosis with
long-term follow-up (median, 221⁄2 months) does not per-
mit a definite conclusion. However, our findings suggest
that the number of patients in whom chronic venous insuf-
ficiency or venous leg ulceration developed did not differ
from the rates reported in previous studies.
There are two major limitations of our study. First,
clinical follow-up for most of our patients was only 4 weeks.
Therefore we cannot draw reliable conclusions regarding
the overall long-term incidence of chronic venous insuffi-
ciency from this series. Second, our series of patients were
seen at a single center. Therefore a hospital-specific selec-
tion bias cannot fully be excluded. In contrast, the strength
of this study is that, to our knowledge, it is the first to
evaluate the proximal extent of pelvic vein thrombosis and
its association with PE in a large patient sample.
In conclusion, our study indicates that extension of
DVT into the IVC is relatively common and does not
appear to significantly increase the risk for PE, compared
with DVT of the femoral or iliac veins. In addition, in our
large patient sample there were no deaths as a consequence
of thromboembolic events, even though IVC involvement
did not influence our standard treatment regimen with
anticoagulation therapy, compression therapy, and walk-
ing.
Statistical analysis was performed by G. Nirnberger,
MD, Bioconsult, Vienna, Austria.
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